stem-cells-istock-577639302_posteriori
posteriori / iStockphoto.com
1 October 2018Asia

Novartis signs deal to bring CAR T therapy to China

Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
5 September 2019   CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat.

More on this story

Big Pharma
5 September 2019   CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat.

More on this story

Big Pharma
5 September 2019   CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat.